HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C.

AbstractBACKGROUND:
The accurate assessment of liver fibrosis among hemodialysis patients with chronic hepatitis C (CHC) is important for both treatment and for follow up strategies. Applying the non-invasive methods in general population with viral hepatitis have been successful but the applicability of the aminotransferase/platelet ratio index (APRI) or the fibrosis-4 index (FIB-4) in hemodialysis patients need further evaluation.
MATERIALS AND METHODS:
We conducted a prospective, multi-center, uremic cohort to verify the applicability of APRI and FIB-4 in identifying liver fibrosis by reference with the standard transient elastography (TE) measures.
RESULTS:
There were 116 CHC cases with valid TE were enrolled in our analysis. 46 cases (39.6%) were classified as F1, 35 cases (30.2%) as F2, 11 cases (9.5%) as F3, and 24 cases (20.7%) as F4, respectively. The traditional APRI and FIB-4 criteria did not correctly identify liver fibrosis. The optimal cut-off value of APRI was 0.28 and of FIB-4 was 1.91 to best excluding liver cirrhosis with AUC of 76% and 77%, respectively. The subgroup analysis showed that female CHC hemodialysis patients had better diagnostic accuracy with 74.1% by APRI. And CHC hemodialysis patients without hypertension had better diagnostic accuracy with 78.6% by FIB-4.
CONCLUSIONS:
This study confirmed the traditional category level of APRI and FIB-4 were unable to identify liver fibrosis of CHC hemodialysis patients. With the adjusted cut-off value, APRI and FIB-4 still showed suboptimal diagnostic accuracy. Our results suggest the necessary of TE measures for liver fibrosis in the CHC uremic population.
AuthorsJia-Jung Lee, Yu-Ju Wei, Ming-Yen Lin, Sheng-Wen Niu, Po-Yao Hsu, Jiun-Chi Huang, Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Szu-Chia Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Jer-Ming Chang, Shang-Jyh Hwang, Chung-Feng Huang, Yi-Wen Chiu, Wan-Long Chuang, Ming-Lung Yu
JournalPloS one (PLoS One) Vol. 15 Issue 11 Pg. e0242601 ( 2020) ISSN: 1932-6203 [Electronic] United States
PMID33216807 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Aspartate Aminotransferases
Topics
  • Aged
  • Aspartate Aminotransferases (blood)
  • Female
  • Hepacivirus (isolation & purification)
  • Hepatitis B virus (isolation & purification)
  • Hepatitis C, Chronic (pathology)
  • Humans
  • Liver (pathology)
  • Liver Cirrhosis (diagnosis, pathology)
  • Male
  • Middle Aged
  • Platelet Count
  • Prospective Studies
  • Renal Dialysis
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: